📰 Repligen Corp News
Page 3 - Repligen Corp News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Repligen Corp. Real-time updates on events, politics, business and more.
August 18, 2023
/PRNewswire/ -- The COVID-19 pandemic had a notable impact on the pharmaceutical filtration manufacturing market in North America. Increased demand for...
August 15, 2023
Global Pharmaceutical Filtration Market 2023-2027. The pharmaceutical filtration market is forecasted to grow by USD 10,219.87 mn during 2022-2027,...
June 16, 2023
Acumen Pharmaceuticals (NASDAQ:ABOS – Get Rating) and Repligen (NASDAQ:RGEN – Get Rating) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, risk, profitability, valuation, earnings and dividends. Risk and Volatility Acumen Pharmaceuticals has a beta of -1.55, suggesting […]
June 16, 2023
Repligen (NASDAQ:RGEN – Get Rating) and Acumen Pharmaceuticals (NASDAQ:ABOS – Get Rating) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, risk, dividends, analyst recommendations, profitability, earnings and valuation. Analyst Recommendations This is a summary of recent ratings and recommmendations […]
June 13, 2023
American Capital Management Inc. boosted its position in Repligen Co. (NASDAQ:RGEN – Get Rating) by 14.5% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 140,751 shares of the biotechnology company’s stock after purchasing an additional 17,827 shares during the quarter. American […]
June 13, 2023
American Capital Management Inc. lifted its holdings in Repligen Co. (NASDAQ:RGEN – Get Rating) by 14.5% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 140,751 shares of the biotechnology company’s stock after buying an additional 17,827 shares during the quarter. American Capital Management Inc. […]
June 11, 2023
The Manufacturers Life Insurance Company boosted its position in shares of Repligen Co. (NASDAQ:RGEN – Get Rating) by 1.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 55,557 shares of the biotechnology company’s stock after acquiring an additional 695 shares during the […]
June 9, 2023
The Business Research Companys Protein A Resin Global Market Report 2023 – Market Size, Trends, And Global Forecast 2023-2032